Median Technologies S.A. | Small-cap | Healthcare
€2.15
-9.66%
| Median Technologies Stock Comparison:
Median Technologies vs Eurobio ScientificMedian Technologies vs Affluent MedicalMedian Technologies vs Carmat S.AMedian Technologies vs Novacyt S.AMedian Technologies vs Diagnostic MedicalMedian Technologies vs CAC 40 | Market
Overview Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 22.9M
Gross Profit 23.8M 103.86%
Operating Income -22.4M -97.46%
Net Income -25.2M -109.99%
EPS (Diluted) -€1.37

Balance Sheet Metrics

Total Assets 24.4M
Total Liabilities 58.3M
Shareholders Equity -34.0M

Cash Flow Metrics

Operating Cash Flow -20.1M
Free Cash Flow -19.0M

Revenue & Profitability Trend

Median Technologies Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue22.9M22.2M23.7M20.5M13.5M
Cost of Goods Sold-886.0K-1.0M-750.0K117.0K135.0K
Gross Profit23.8M23.2M24.4M20.4M13.3M
Operating Expenses19.6M19.3M18.6M13.7M9.6M
Operating Income-22.4M-22.9M-23.2M-11.4M-8.7M
Pre-tax Income-25.1M-22.9M-19.7M-18.9M-12.8M
Income Tax144.0K76.0K521.0K437.0K-8.0K
Net Income-25.2M-23.0M-20.2M-19.3M-12.8M
EPS (Diluted)-€1.37-€1.25-€1.28-€1.25-€1.06

Income Statement Trend

Median Technologies Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets20.5M31.9M31.5M47.5M23.4M
Non-Current Assets3.9M4.0M3.2M1.8M1.9M
Total Assets24.4M35.9M34.8M49.4M25.3M
Liabilities
Current Liabilities44.1M22.7M23.4M27.3M20.3M
Non-Current Liabilities14.2M23.5M18.6M17.2M16.3M
Total Liabilities58.3M46.2M42.0M44.4M36.6M
Equity
Total Shareholders Equity-34.0M-10.3M-7.3M4.9M-11.4M

Balance Sheet Composition

Median Technologies Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income-25.2M-23.0M-20.2M-19.3M-12.8M
Operating Cash Flow-20.1M-18.5M-10.8M-15.9M-11.8M
Investing Activities
Capital Expenditures-227.0K-1.3M-1.4M-437.0K-293.0K
Investing Cash Flow-313.0K-1.3M-1.4M-627.0K-261.0K
Financing Activities
Dividends Paid-----
Financing Cash Flow8.6M21.6M123.0K33.6M14.6M
Free Cash Flow-19.0M-21.5M-17.2M-10.6M-5.8M

Cash Flow Trend

Median Technologies Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) -1.02
Forward P/E -1.19
Price to Sales 1.11
PEG Ratio -1.19

Profitability Ratios

Profit Margin -109.93%
Operating Margin -76.84%
Return on Equity 74.31%
Return on Assets -46.71%

Financial Health

Current Ratio 0.46
Debt to Equity -0.98
Beta 0.80

Per Share Data

EPS (TTM) -€1.37
Book Value per Share -€1.84
Revenue per Share €1.24

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
almdt25.6M-1.02-74.31%-109.93%-0.98
Eurobio Scientific 253.4M64.741.422.26%2.58%5.46
Affluent Medical 53.3M-3.551.73-48.69%-275.50%0.54
Carmat S.A 24.8M--100.52%-336.56%-1.13
Novacyt S.A 34.9M-0.820.72-57.28%-212.73%24.81
Diagnostic Medical 24.2M-8.641.96-20.20%-5.90%141.76

Financial data is updated regularly. All figures are in the company's reporting currency.